Gelteq Limited (GELS:NASDAQ) closed at $0.446 on October 16, 2026, up 1.39% on the day. The stock trades 77.8% below its 52-week high of $2.01 and 15.2% above its 52-week low of $0.387. Over the past year, it lost 63.4%. Gelteq Limited is part of the Miscellaneous sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -9.02% | -23.10% | -24.41% | -36.29% | -63.44% |
In 252 trading sessions since October 16, 2025, GELS closed higher on 97 days (38%). Its best day was June 11, 2026 (+197.09%) and its worst was June 12, 2026 (-35.29%). The stock moved 10% or more in a single session 27 times. It opened at least 5% above the previous day's high 7 times.
A "white label" gel-based delivery solution is where we produce a product that other companies rebrand as their own product. Our principal products are edible gels and their application in gel-based dosage forms. Our current product suite consists of multiple products that sit within five core verticals-for pets, sports, pharmaceutical (pharma), over-the-counter (OTC) and nutraceutical-all of which leverage our patent pending multiple-ingredient dosage forms, and that we expect to have a wide range of applications and consumers. We currently focus our efforts on out-licensing our technology to companies to develop and create new products they can manufacture and sell within their established and researched markets, while we continue to manufacture our existing products under license. Of our products already licensed, two clients have placed initial orders for nutraceutical products, and there have been four other products in the sports vertical ordered.
Find more stocks like GELS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.